The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion
- PMID: 3500113
- DOI: 10.1089/hyb.1987.6.469
The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion
Abstract
UC 729-6, a 6-thioguanine resistant human lymphoblastoid B cell line, was fused with human lymphocytes by electrofusion. Resulting human-human hybridomas were tetraploid, expressed markers derived from both fusion parents, and secreted approximately 1 microgram Ig/10(6) cells/ml/day. Cells to be used for electrofusion were washed in 0.3M mannitol, and fusions were performed with glass slides, 1.0 ml, and 50.0 ml chambers. Fusion sequences consisted of alignment, compression, and the fusion event itself. The optimal cell concentration for electrofusion was 5 X 10(6)/ml. Fusion efficiencies of human lymphocytes were ranked as follows: lymphoma cells greater than lymph node lymphocytes greater than PBL. 80% of the lymphoma hybridomas, 60% of the lymph node hybridomas, and 40% of the PBL hybridomas were Ig secretors. These data demonstrate that the UC 729-6 cell line is a suitable vector for generating human-human hybridomas by electrofusion.
Similar articles
-
UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.Proc Natl Acad Sci U S A. 1983 Oct;80(20):6327-31. doi: 10.1073/pnas.80.20.6327. Proc Natl Acad Sci U S A. 1983. PMID: 6604917 Free PMC article.
-
Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.Hum Antibodies Hybridomas. 1992 Jan;3(1):48-53. Hum Antibodies Hybridomas. 1992. PMID: 1576322
-
Efficient generation of stable antibody forming hybridoma cells by electrofusion.Hybridoma. 1989 Feb;8(1):107-15. doi: 10.1089/hyb.1989.8.107. Hybridoma. 1989. PMID: 2925206
-
Generation of stable human autoantibody-secreting B cell hybridomas.Mol Biol Rep. 1992 May;16(2):65-73. doi: 10.1007/BF00419750. Mol Biol Rep. 1992. PMID: 1608399 Review. No abstract available.
-
Hybridoma technologies for antibody production.Immunotherapy. 2011 Mar;3(3):371-80. doi: 10.2217/imt.11.4. Immunotherapy. 2011. PMID: 21395379 Review.
Cited by
-
Development of human monoclonal antibodies: A review.Cytotechnology. 1996 Jan;21(3):183-93. doi: 10.1007/BF00365341. Cytotechnology. 1996. PMID: 22358750
-
Exploring the native human antibody repertoire to create antiviral therapeutics.Curr Top Microbiol Immunol. 2008;317:155-83. doi: 10.1007/978-3-540-72146-8_6. Curr Top Microbiol Immunol. 2008. PMID: 17990793 Free PMC article. Review.